Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA

Neurochemistry International

Volumn 58, Issue 3, 2011, Pages 337-343

  Rodríguez González, Raquel ^a   Agulla, Jesús ^a   Pérez Mato, María ^a   Sobrino, Tomás ^a   Castillo, José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Ischemia; Neuroprotection; Neuroserpin; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; CASPASE 3; CYCLOOXYGENASE 2; GELATINASE B; GLUCOSE; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROSERPIN; OXYGEN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN ISCHEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; COCULTURE TECHNIQUES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SERPINS; TISSUE PLASMINOGEN ACTIVATOR;

ANIMALIA; RATTUS;

EID: 79951581270     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.12.006     Document Type: Article

References (37)

1. C. Albuquerque, D.J. Joseph, P. Choudhury, and A.B. MacDermott Dissection, Plating, and Maintenance of Cortical Astrocyte Cultures 2009 Cold Spring Harb Protocols 10.1101/pdb.prot5273
2. D. Belorgey, L.K. Sharp, D.C. Crowther, M. Onda, J. Johansson, and D.A. Lomas Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB Eur. J. Biochem. 271 2004 3360 3367 (Pubitemid 39120335)
3. E.E. Benarroch Tissue plasminogen activator: beyond thrombolysis Neurology 69 2007 799 802 (Pubitemid 47300938)
4. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. L. Cartier, O. Hartley, M. Dubois-Dauphin, and K.H. Krause Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases Brain Res. Brain Res. Rev. 48 2005 16 42 (Pubitemid 40215781)
6. P. Cinelli, R. Madani, N. Tsuzuki, P. Vallet, M. Arras, C.N. Zhao, T. Osterwalder, T. Rulicke, and P. Sonderegger Neuroserpin, a neuroprotective factor in focal ischemic stroke Mol. Cell. Neurosci. 18 2001 443 457 (Pubitemid 34008386)
7. A.W. Clark, C.A. Krekoski, S.S. Bou, K.R. Chapman, and D.R. Edwards Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia Neurosci. Lett. 238 1997 53 56 (Pubitemid 28015782)
8. G. Conductier, N. Blondeau, A. Guyon, J.L. Nahon, and C. Rovre The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases J. Neuroimmunol. 224 2010 93 100
9. L.A. Cunningham, M. Wetzel, and G.A. Rosenberg Multiple roles for MMPs and TIMPs in cerebral ischemia Glia 50 2005 329 339 (Pubitemid 40780839)
10. W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Dávalos, D. Guidetti, V. Larrue, K.R. Lees, Z. Medeghri, T. Machnig, D. Schneider, R. von Kummer, N. Wahlgren, and D. Toni ECASS investigators N. Engl. J. Med. 359 2008 1317 1329
11. J.H. Heo, J. Lucero, T. Abumiya, J.A. Koziol, B.R. Copeland, and G.J. del Zoppo Matrix metalloproteinases increase very early during experimental focal cerebral ischemia J. Cereb. Blood Flow. Metab. 19 1999 624 633 (Pubitemid 30161214)
12. J. Herz LRP: a bright beacon at the blood-brain barrier J. Clin. Invest. 112 2003 1483 1485 (Pubitemid 38056274)
13. B. Hinz, and K. Brune Cyclooxygenase-2-10 years later J. Pharmacol. Exp. Ther. 300 2002 367 375
14. O. Hurtado, I. Lizasoain, P. Fernandez-Tome, A. Alvarez-Barrientos, J.C. Leza, P. Lorenzo, and M.A. Moro TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate J. Cereb. Blood Flow. Metab. 22 2002 576 585 (Pubitemid 34477779)
15. T. Katayama, M. Minami, M. Nakamura, M. Ito, H. Katsuki, A. Akaike, and M. Satoh Excitotoxic injury induces production of monocyte chemoattractant protein-1 in rat cortico-striatal slice cultures Neurosci. Lett. 328 2002 277 280 (Pubitemid 34876665)
16. J.S. Kim, S.C. Gautam, M. Chopp, C. Zaloga, M.L. Jones, P.A. Ward, and K.M. Welch Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat J. Neuroimmunol. 56 1995 127 134
17. N. Lebeurrier, G. Liot, J.P. Lopez-Atalaya, C. Orset, M. Fernandez-Monreal, P. Sonderegger, C. Ali, and D. Vivien The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo Mol. Cell. Neurosci. 30 2005 552 558 (Pubitemid 41721172)
18. H.Y. Lee, I.Y. Hwang, H. Im, J.Y. Koh, and Y.H. Kim Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons J. Neurochem. 101 2007 1236 1247 (Pubitemid 46718808)
19. S.R. Lee, S.Z. Guo, R.H. Scannevin, B.C. Magliaro, K.J. Rhodes, X. Wang, and E.H. Lo Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators Neurosci. Lett. 417 2007 1 5 (Pubitemid 46533879)
20. G. Liot, B.D. Roussel, N. Lebeurrier, K. Benchenane, J.P. Lopez-Atalaya, D. Vivien, and C. Ali Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity J. Neurochem. 98 2006 1458 1464 (Pubitemid 44200437)
21. D. Liu, T. Cheng, H. Guo, J.A. Fernandez, J.H. Griffin, X. Song, and B.V. Zlokovic Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C Nat. Med. 10 2004 1379 1383 (Pubitemid 40022721)
22. A. Makarova, I. Mikhailenko, T.H. Bugge, K. List, D.A. Lawrence, and D.K. Strickland The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes J. Biol. Chem. 278 2003 50250 50258 (Pubitemid 37548866)
23. M.G. Medina, M.D. Ledesma, J.E. Dominguez, M. Medina, D. Zafra, F. Alameda, C.G. Dotti, and P. Navarro Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation EMBO J. 24 2005 1706 1716 (Pubitemid 40704981)
24. O. Nicole, F. Docagne, C. Ali, I. Margaill, P. Carmeliet, E.T. MacKenzie, D. Vivien, and A. Buisson The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
25. R. Polavarapu, M.C. Gongora, H. Yi, S. Ranganthan, D.A. Lawrence, D. Strickland, and M. Yepes Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit Blood 109 2007 3270 3278 (Pubitemid 46572512)
26. J.K. Rhodes, J. Sharkey, and P.J. Andrews The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat J. Neurotrauma 26 2009 507 525
27. C. Romera, O. Hurtado, S.H. Botella, I. Lizasoain, A. Cardenas, P. Fernandez-Tome, J.C. Leza, P. Lorenzo, and M.A. Moro In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway J. Neurosci. 24 2004 1350 1357 (Pubitemid 38222985)
28. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N. Eng. J. Med. 333 1995 1581 1587
29. K. Tsuji, T. Aoki, E. Tejima, K. Arai, S.R. Lee, D.N. Atochin, P.L. Huang, X. Wang, J. Montaner, and E.H. Lo Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia Stroke 36 2005 1954 1959 (Pubitemid 41266533)
30. J.Y. Wang, A.Y. Shum, C.C. Chao, and J.S. Kuo Production of macrophage inflammatory protein-2 following hypoxia/reoxygenation in glial cells Glia 32 2000 155 164
31. S. Wang, S.R. Lee, S.Z. Guo, W.J. Kim, J. Montaner, X. Wang, and E.H. Lo Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes Stroke 37 2006 1910 1912 (Pubitemid 44297750)
32. X. Wang, S.R. Lee, K. Arai, K. Tsuji, G.W. Rebeck, and E.H. Lo Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator Nat. Med. 9 2003 1313 1317 (Pubitemid 37279856)
33. X.F. Wang, and M.S. Cynader Effects of astrocytes on neuronal attachment and survival shown in a serum-free co-culture system Brain Res. Protoc. 4 1999 209 216 (Pubitemid 29396421)
34. Y. Yamasaki, Y. Matsuo, N. Matsuura, H. Onodera, Y. Itoyama, and K. Kogure Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats Stroke 26 1995 318 322 discussion 322-313
35. M. Yepes, M. Sandkvist, M.K. Wong, T.A. Coleman, E. Smith, S.L. Cohan, and D.A. Lawrence Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis Blood 96 2000 569 576 (Pubitemid 30463377)
36. Z. Zhang, L. Zhang, M. Yepes, Q. Jiang, Q. Li, P. Arniego, T.A. Coleman, D.A. Lawrence, and M. Chopp Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke Circulation 106 2002 740 745 (Pubitemid 34851936)
37. G. Zhao, J.N. Reynolds, and M.P. Flavin Temporal profile of tissue plasminogen activator (tPA) and inhibitor expression after transient focal cerebral ischemia Neuroreport 14 2003 1689 1692 (Pubitemid 37323754)